Antihypertensive drugs

Ratliff, 2002, Captopril-induced lupus, J Rheumatol, 29, 1807 Reidenberg, 1984, Development of antinuclear antibody in patients treated with high doses of captopril, Arthritis Rheum, 27, 579, 10.1002/art.1780270516 Parodi, 2002, Fosinopril as a possible pemphigus-inducing drug, Dermatology, 204, 138, 10.1159/000051833 Kränke, 2002, Cold urticaria and angiotensin converting enzyme inhibitor, Acta Dermatol Venereol, 82, 149, 10.1080/00015550252948284 Tosetti, 2002, Angiotensin-converting enzyme inhibitors and diarrhoea, J Clin Gastroenterol, 35, 105, 10.1097/00004836-200207000-00029 Ohkoshi, 2002, Reversible ageusia induced by losartan: a case report, Eur J Neurol, 9, 315, 10.1046/j.1468-1331.2002.00389.x Tabak, 2002, Losartan-induced hepatic injury, J Clin Gastroenterol, 34, 585, 10.1097/00004836-200205000-00022 Neunteufl, 2002, Endothelin receptor antagonists in cardiology clinical trials, Expert Opin Invest Drugs, 11, 431, 10.1517/13543784.11.3.431 Wu Wong, 2002, Endothelin receptor antagonists as therapeutic agents for cancer, Curr Opin Invest Drugs, 3, 1234 Chow, 2002, Endothelin receptor antagonists and cerebral vasospasm An update, Neurosurgery, 51, 1333, 10.1227/01.NEU.0000309108.94215.71 Doggrell, 2002, The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system, Expert Opin Invest Drugs, 11, 1537, 10.1517/13543784.11.11.1537 Rubin, 2002, New Bosentan therapy for pulmonary arterial hypertension, Engl J Med, 346, 896, 10.1056/NEJMoa012212 Badesch, 2002, Complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension, Curr Ther Res Clin Exp, 63, 227, 10.1016/S0011-393X(02)80029-7 Kalra, 2002, Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?, Int J Cardiol, 85, 195, 10.1016/S0167-5273(02)00182-1 Fouassier, 2002, Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan, J Hepatol, 37, 184, 10.1016/S0168-8278(02)00107-1 Dingemanse, 2002, Influence of severe renal dysfunction on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist, Int J Clin Pharmacol Ther, 40, 310, 10.5414/CPP40310 Dingemanse, 2002, Entry-into-humans study with tezosentan, an intravenous dual endothelin receptor antagonist, J Cardiovasc Pharmacol, 39, 795, 10.1097/00005344-200206000-00004 Dingemanse, 2002, Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects, Br J Clin Pharmacol, 53, 355, 10.1046/j.1365-2125.2002.01158.x Delva, 2002, Effects of clonidine in schizophrenic patients with primary polydipsia: three single case studies, Prog Neuropsychopharmacol Biol Psychiatry, 26, 387, 10.1016/S0278-5846(01)00246-9 Backo, 2002, Clonidine-induced hypertension in a patient with a spinal lesion, Ann Pharmacother, 36, 1396, 10.1345/aph.1C048 Prisant, 2002, Transdermal clonidine skin reactions, J Clin Hypertens (Greenwich), 4, 136, 10.1111/j.1524-6175.2001.00954.x Klein-Schwartz, 2002, Trends and toxic effects from pediatric clonidine exposures, Arch Pediatr Adolesc Med, 156, 392, 10.1001/archpedi.156.4.392 Akduman, 2001, Terazosin, doxazosin, and prazosin: current clinical experience, Urology, 58, 49, 10.1016/S0090-4295(01)01302-4 Prys-Roberts, 2002, Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma, World J Surg, 26, 1037, 10.1007/s00268-002-6667-z Messerli, 2001, Doxazosin and congestive heart failure, J Am Coll Cardiol, 38, 1295, 10.1016/S0735-1097(01)01534-0 Mansoor, 2002, Stroke associated with alpha blocker therapy for benign prostatic hypertrophy, J Natl Med Assoc, 94, 1 Anegon, 2002, A post-marketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension, Clin Ther, 24, 786, 10.1016/S0149-2918(02)85152-9 Bargout, 2001, A 44-year-old man with a pruritic skin rash, Cleve Clin J Med, 68, 952, 10.3949/ccjm.68.11.952 Shirwany, 2002, Very large pericardial effusion attributable to minoxidil: resolution without drainage of fluid, Echocardiography, 19, 513, 10.1046/j.1540-8175.2002.00513.x